Benaroya Research Institute sincerely thanks the Rasmuson Foundation of Anchorage, Alaska, for providing a $1 million grant to bring education and access to clinical trials to Alaskans suffering from autoimmune diseases, cancer and many other conditions.
- The grant enrolled a total of 87 Alaskans into clinical trials.
- They joined more than 30 different clinical trials for diseases including type 1 diabetes, multiple sclerosis, rheumatoid arthritis, scleroderma, hepatitis and many types of cancer.
- Many of these patients graciously donated blood and tissue samples for the BRI biorepositories to help advance research.
- Alaskan study participants increased the understanding and treatment for a variety of diseases. For example, multiple Alaskans were enrolled onto a hepatitis C trial for a drug called Boceprevir. Based on this research, the drug has been approved by the FDA and is now the standard of care for treating hepatitis C.
- The grant provided participants with 431 round-trip visits to Seattle from Hoonah to Fairbanks and numerous cities in between.
- BRI and Virginia Mason staff provided health information to the state by talking with clinicians and attending health fairs and conferences.
Originally Publish in BRING IT ON Newsletter - Winter 2013
January 1, 2014
Like What You Read?
Stay informed! Be sure you receive regular research updates. Subscribe
Join the Conversation
This blog does not provide medical advice, nor is it a substitute
for professional medical advice, diagnosis or treatment.